Revisiting the Role of Intravitreal Triamcinolone in Diabetic Macular Edema: 12-Month Outcomes after Bevacizumab Failure
Abstract Introduction Refractory diabetic macular edema (DME) is challenging in resource-limited settings, where costly alternatives such as non-bevacizumab anti-vascular endothelial growth factors (VEGFs) and corticosteroid implants are inaccessible. In Thailand, budget constraints exclude these dr...
Kaydedildi:
| Asıl Yazarlar: | , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Adis, Springer Healthcare
2025-06-01
|
| Seri Bilgileri: | Ophthalmology and Therapy |
| Konular: | |
| Online Erişim: | https://doi.org/10.1007/s40123-025-01172-5 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|